Back
Company

Lunit

vendor1 tracked tool

Company Intelligence

Lunit Marks Go-Live in Groundbreaking National AI Cancer Screening Program in BreastScreen NSW

10 hours agodeployment

Lunit INSIGHT DBT v1.1 FDA 510(k) Clearance

a day agofda

New Lunit Study Demonstrates Universal AI Model for Analysis of Immunohistochemistry Images

3 days agoevidence

Lunit Expands AI-Powered Breast Cancer Screening Across the Stockholm Region

5 days agodeployment

Lunit Study in Radiology Highlights Trust Gap Between Radiologists and AI in Breast Cancer Screening

5 days agoevidence

Lunit Surpasses 330+ Sites and 1M Annual Screenings as Breast Imaging AI Moves into Clinical Practice

5 days agofda

A large validation study of AI-powered PD-L1 analyzer compared to pathologists’ assessment of PD-L1 expression in lung cancer

6 days agoevidence

Lunit’s AI Now Powers Cancer Screening for Over 8.5 Million People Across Italy’s Public Health System

6 days agodeployment

Lunit Partners with Severance Hospital to Expand Medical AI Foundation Model

7 days agodeployment

Lunit Selected as Exclusive AI Partner for Spain's Valencian Community Breast Screening Program

10 days agodeployment

Health system will use AI instead of radiologists for breast imaging 2nd reads

11 days agodeployment

Lunit to Present AI Study on EGFR Mutation Prediction in NSCLC at AACR 2025 in Collaboration with AstraZeneca

12 days agodeployment

Lunit Expands AI-Powered Breast Cancer Screening Across the Stockholm Region

12 days agodeployment

Lunit to deploy AI chest X-ray solution to Saudi Arabia's largest medical group

18 days agodeployment

Lunit AI Proven Successful in 1-Year Breast Cancer Screening Deployment

20 days agodeployment